Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Jay Lichter

AddedMar 31, 2024

UpdatedMay 31, 2026

Jay Lichter

Jay Lichter

CEO, Fortis Therapeutics

Jay Lichter's Career

Fortis Therapeutics

Fortis Therapeutics

San Diego, CA, US

CEO· C-Suite · Management

Sova Pharmaceuticals

Sova Pharmaceuticals

Los Angeles, CA, US

Board Member· Board

Nerio Therapeutics

Nerio Therapeutics

Los Angeles, CA, US

Co-Founder

Enlibrium

San Francisco, CA, US

Board Member· Board

Avelas Biosciences

Avelas Biosciences

Los Angeles, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Jay Lichter's Career

Fortis Therapeutics

Fortis Therapeutics

Series A$58M752016San Diego, CA, US

CEO· C-Suite · Management

Leadership at Fortis Therapeutics

Similar to Fortis Therapeutics

AbproWoburn, MA, USResearch, Therapeuticsest. 2007AbproWoburn, MA, US · est. 2007

Abpro Corp: A global biotech firm developing advanced antibody therapeutics for severe diseases.

Seed · $42.4M38

Solve TherapeuticsBelmont, CA, USDrug Developmentest. 2021Solve TherapeuticsBelmont, CA, US · est. 2021

Solve Therapeutics: A California-based biopharmaceutical firm innovating in antibody drug conjugates since 2021.

Series A · $126M19

AltruBioLos Altos, CA, USAntibody Therapeuticsest. 2000AltruBioLos Altos, CA, US · est. 2000

AltruBio, a global biotech firm, develops targeted antibody therapeutics for cancer and immune diseases.

Series A · $102.6M5

Amberstone BiosciencesLaguna Hills, CA, USTherapeutic Antibodiesest. 2018Amberstone BiosciencesLaguna Hills, CA, US · est. 2018

Amberstone Biosciences innovatively develops therapeutic antibodies for unmet medical needs.

Series A · $13.3M19

Sova Pharmaceuticals

Sova Pharmaceuticals

Public$4M102010Los Angeles, CA, US

Board Member· Board

Leadership at Sova Pharmaceuticals

Gary PaceBoard Member

Court R. TurnerBoard Member

Similar to Sova Pharmaceuticals

SOV TherapeuticsMorrisville, NC, USTherapeutics, Treatmentsest. 2009SOV TherapeuticsMorrisville, NC, US · est. 2009

SOV Therapeutics: A NC-based biotech firm specializing in oral testosterone replacement therapies.

Savoy PharmaceuticalsSalt Lake City, UT, USPharmaceuticalsest. 2004Savoy PharmaceuticalsSalt Lake City, UT, US · est. 2004

Savoy Pharmaceuticals Inc.: Specializing in oncology, virology, and immunology treatments across the US.

Angel · $2.5M11

Amerigen PharmaceuticalsLyndhurst, NJ, USDrugs, Pharmaceuticalsest. 2007Amerigen PharmaceuticalsLyndhurst, NJ, US · est. 2007

Amerigen Pharmaceuticals: Manufacturing and selling quality human and veterinary drugs since 2007.

Public · $35M75

Tioga PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2005Tioga PharmaceuticalsSan Diego, CA, US · est. 2005

Tioga Pharmaceuticals: Innovating gastrointestinal disease treatments as a leading pharma manufacturer.

Public · $57M30

Nerio Therapeutics

Nerio Therapeutics

Series A$6.5M62019Los Angeles, CA, US

Co-Founder

Leadership at Nerio Therapeutics

Sanford J. MadiganCEO

Tighe ReardonCo-Founder

Similar to Nerio Therapeutics

Nerx BiosciencesIndianapolis, IN, USCancer Therapeuticsest. 2009Nerx BiosciencesIndianapolis, IN, US · est. 2009

US-based NĒRx BioSciences Inc, founded in 2009, specializes in discovering and developing targeted cancer therapeutics.

Seed · $500k11

Nerium BiotechnologySan Antonio, TX, USPharmaceuticalsest. 2006Nerium BiotechnologySan Antonio, TX, US · est. 2006

Nerium Biotech, a US-based company, develops oleander-based products for treating cancer, HIV/AIDS, Hepatitis C, and aging skin.

Public · $288.5k33

Enlaza TherapeuticsLos Angeles, CA, USBiotechnologyest. 2020Enlaza TherapeuticsLos Angeles, CA, US · est. 2020

Enlaza Therapeutics: A California-based biotech research firm, founded in 2020.

Nereid TherapeuticsBoston, MA, USDrug Discoveryest. 2020Nereid TherapeuticsBoston, MA, US · est. 2020

Nereid Therapeutics: Innovating drug discovery with proprietary technologies for new disease treatments.

Series A · $50M12

Enlibrium

Acquired$15M02015San Francisco, CA, US

Board Member· Board

Leadership at Enlibrium

Heather PrestonBoard Member

David CampbellCo-Founder

Michael JungCo-Founder

Richard PietrasCo-Founder

Avelas Biosciences

Avelas Biosciences

Public$41.9M362008Los Angeles, CA, US

Board Member· Board

Leadership at Avelas Biosciences

Elena StarikovaBoard Member

Roger TsienFounder

Carmine StengoneBoard Member

Susan StimsonBoard Member

Timothy ScottBoard Member

Similar to Avelas Biosciences

LumicellWellesley, MA, USCancer Detectionest. 2008LumicellWellesley, MA, US · est. 2008

US-based Lumicell, a biotech firm, innovates image-guided solutions for cancer surgeries.

Series A · $77.8M64

Blaze BioscienceSeattle, WA, USImaging, Tumor Paintest. 2010Blaze BioscienceSeattle, WA, US · est. 2010

Seattle-based Blaze Bioscience develops tumor paint technology for precise, real-time cancer cell visualization.

Series B · $55.4M38

avelisbiotech.comScottsdale, AZ, USTechnologyest. 2007avelisbiotech.comScottsdale, AZ, US · est. 2007

Avelis LLC: Innovating natural enhancement technologies for plants, water, and animals since 2007.

Vergent BioscienceMinneapolis, MN, USImaging Agentsest. 2016Vergent BioscienceMinneapolis, MN, US · est. 2016

Vergent Bioscience: Pioneering in tumor-targeted molecular imaging for cancer surgery.

Series B · $34.4M13

Jay Lichter's Similar Executives & Operators

Lau Eng BoonBoard Member · Bukalapak

Willix HalimCEO · Bukalapak

Achmad ZakyCo-Founder · Bukalapak

Nugroho HerucahyonoCo-Founder · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

Bo ZhangCo-Founder · DiDi

WILL WEI CHENGBoard Member · DiDi

People Similar to Jay Lichter

Ronald GoldBoard Member · NJ Bio

Kevin AkeroydCEO · PRO Unlimited

Allan StephanCo-Founder · Carewave Medical

Bill KaiglerCo-Founder · sovaSage

Ravi ChamriaCo-Founder · Zeeve